Fordadistrogene Movaparvovec, ECULIZUMAB, Placebo for PF-06939926
C3391003
Phase 3 small_molecule active
Quick answer
Fordadistrogene Movaparvovec, ECULIZUMAB, Placebo for PF-06939926 for DUCHENNE MUSCULAR DYSTROPHY (DMD) is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- DUCHENNE MUSCULAR DYSTROPHY (DMD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active